Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Sep ‘17 |
|
|---|---|---|---|---|---|
| $12.3M | $27.9M | $15.6M | 120% |
|
|
| $12.2M | $14M | $1.76M | 41.3% |
|
|
| $12.1M | $12.7M | $576K | 95.5% |
|
|
354
Novo Nordisk
NVO
$167B
| $12.1M | $30.4M | $18.3M | 56.4% |
|
| $12M | $13.8M | $1.74M | 70.2% |
|
|
| $11.9M | $17.9M | $5.99M | 14.5% |
|
|
| $11.9M | $13.4M | $1.52M | 18.8% |
|
|
| $11.9M | $30.7M | $18.8M | 506% |
|
|
| $11.7M | $12.4M | $722K | 224% |
|
|
| $11.6M | $12.3M | $683K | 233% |
|
|
361
Travere Therapeutics
TVTX
$2.65B
| $11.6M | $13.3M | $1.7M | 19.1% |
|
| $11.6M | $21.4M | $9.8M | 204% |
|
|
| $11.6M | $66.9M | $55.3M | 189% |
|
|
| $11.5M | $28.9M | $17.5M | 58.9% |
|
|
| $11.3M | $90.3M | $78.9M | 27.6% |
|
|
| $11.2M | $14.1M | $2.86M | 79.8% |
|
|
| $11M | $25M | $14M | 24.8% |
|
|
| $10.8M | $22M | $11.2M | 60.1% |
|
|
| $10.8M | $16.2M | $5.44M | 664% |
|
|
| $10.8M | $26.3M | $15.5M | 8.6% |
|
|
| $10.8M | $22.1M | $11.4M | 72.4% |
|
|
| $10.7M | $228M | $217M | 21.7% |
|
|
| $10.6M | $77.3M | $66.7M | 82.9% |
|
|
| $10.6M | $229M | $218M | 180% |
|
|
| $10.6M | $14.2M | $3.65M | 206% |
|